US 12,295,913 B2
Medication container encoding, verification, and identification
Walter J. Bochenko, Encinitas, CA (US); Stephen M. Prince, La Jolla, CA (US); Winthrop De Childers, San Diego, CA (US); Joseph M. Calabro, Del Mar, CA (US); Wallace S. Halliday, Del Mar, CA (US); and Mark Van Veen, Cardiff, CA (US)
Assigned to CRISI Medical Systems, Inc., Franklin Lakes, NJ (US)
Filed by CRISI Medical Systems, Inc., Franklin Lakes, NJ (US)
Filed on Sep. 23, 2020, as Appl. No. 17/030,074.
Application 17/030,074 is a continuation of application No. 16/667,187, filed on Oct. 29, 2019, granted, now 10,813,836.
Application 16/667,187 is a continuation of application No. 16/406,375, filed on May 8, 2019, granted, now 10,492,991.
Application 16/406,375 is a continuation of application No. 15/249,925, filed on Aug. 29, 2016, granted, now 10,327,987, issued on Jun. 25, 2019.
Application 15/249,925 is a continuation of application No. 13/671,752, filed on Nov. 8, 2012, granted, now 9,514,131, issued on Dec. 6, 2016.
Application 13/671,752 is a continuation in part of application No. 13/149,782, filed on May 31, 2011, granted, now 8,328,082, issued on Dec. 11, 2012.
Claims priority of provisional application 61/349,878, filed on May 30, 2010.
Prior Publication US 2021/0069061 A1, Mar. 11, 2021
Int. Cl. A61J 1/18 (2023.01); A61J 1/00 (2023.01); A61J 1/03 (2023.01); A61J 1/14 (2023.01); A61J 1/20 (2006.01); A61J 7/04 (2006.01); A61M 5/168 (2006.01); B65B 3/00 (2006.01); G06K 7/10 (2006.01); G06K 7/14 (2006.01)
CPC A61J 1/18 (2013.01) [A61J 1/00 (2013.01); A61J 1/03 (2013.01); A61J 1/1412 (2013.01); A61J 1/2048 (2015.05); A61J 1/2096 (2013.01); A61J 7/04 (2013.01); A61M 5/168 (2013.01); B65B 3/003 (2013.01); G06K 7/10405 (2013.01); G06K 7/10445 (2013.01); G06K 7/1413 (2013.01); A61J 2200/30 (2013.01); A61J 2200/70 (2013.01); A61J 2205/10 (2013.01); A61J 2205/50 (2013.01); A61J 2205/60 (2013.01)] 16 Claims
OG exemplary drawing
 
1. A computer-implemented method comprising:
obtaining, with at least one processor, from a medication information source, medication identification information associated with a first medication container;
obtaining, with at least one processor, from at least one additional medication information source, additional medication information; and
generating, with at least one processor, based on the medication identification information and the additional medication information, encoded medication identification information for encoding an identifier associated with a second medication container,
wherein the obtaining the additional medication information further includes:
obtaining, with at least one processor, from a fluid composition sensor, medication composition information associated with one or more fluid constituents and relative concentrations of the one or more fluid constituents contained in the first medication container, wherein the encoded medication identification information is further generated based on the medication composition information, and
wherein the method further comprises:
measuring, with the fluid composition sensor, the one or more fluid constituents and the relative concentrations of the one or more fluid constituents contained in the first medication container.